|
|
|
|
|
Product Name
|
Angiotensin Converting Enzyme 2 peptide (Carboxy catalytic domain)
|
|
Product type
|
Proteins and Peptides
|
|
Peptide
|
Synthetic peptide Angiotensin Converting Enzyme 2.
This peptide was used as an immunogen for ab38941 - Angiotensin Converting Enzyme 2 antibody - Carboxy catalytic domain.
|
|
Specificity
|
We have a range of domain specific antibodies for this target. For a full list please see all Angiotensin Converting Enzyme 2 antibodies
|
|
Tested applications
(see key)
|
ELISA, WB
|
|
Application notes
(see key)
|
Recommended dilutions
ELISA: Use at an assay dependent dilution. WB: Use at an assay dependent dilution. This peptide can be used with studies using ab38941. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Research areas
|
Cardiovascular >> Vasculature >> Vasoconstriction >> Other
Cardiovascular >> Heart >> Contractility >> Inotropics
Cardiovascular >> Blood >> Blood Pressure regulation
Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Metalloprotease >> ACEs
|
|
Relevance
|
Angiotensin converting enzyme 2 (ACE2) plays a central role in vascular, renal, and myocardial physiology. In contrast to its homolog ACE, ACE2 expression is restricted to heart, kidney, and testis. Recently ACE2 has also been shown to be a functional receptor of the SARS coronavirus. The normal function of ACE2 is to convert the inactive vasoconstrictor angiotensin I (AngI) to Ang1-9 and the active form AngII to Ang1 7, unlike ACE, which converts AngI to AngII. While the role of these vasoactive peptides is not well understood, lack of ACE2 expression in ace2-/ace2- mice leads to severely reduced cardiac contractility, indicating its importance in regulating heart function. ACE1 inhibitors such as catopril and lisinopril do not block ACE2 activity. The full length sequence for ACE2 encodes an 805 amino acid protein with predicted mass of 92.46 kDa and a pI of 5.22.
|
|
|
Alternative names Angiotensin Converting Enzyme 2 peptide (Carboxy catalytic domain) (ab41283) |
|
Purity
|
>95% by SDS-PAGE
|
|
Storage buffer
|
Preservative: None
Constituents: 0.001% Tween 20, 30mM HEPES, 2mM EDTA, 150mM Sodium chloride, pH 6.75
|
|
Form
|
Liquid
|
|
Concentration
|
1.000 mg/ml
|
|
Storage instructions
|
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this Angiotensin Converting Enzyme 2 peptide (Carboxy catalytic domain) is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
| |
|
Search PubMed (MEDLINE) for references to Angiotensin Converting Enzyme 2
|
| |
Angiotensin Converting Enzyme 2 peptide (Carboxy catalytic domain) - more information
|
Customer reviews (feedback) regarding Angiotensin Converting Enzyme 2 peptide (Carboxy catalytic domain) |
Customer FAQs regarding Angiotensin Converting Enzyme 2 peptide (Carboxy catalytic domain) |
Protocols for Angiotensin Converting Enzyme 2 peptide (Carboxy catalytic domain) |
Price and availability of products related to Angiotensin Converting Enzyme 2 peptide (Carboxy catalytic domain) |
| |
Angiotensin Converting Enzyme 2 peptide (Carboxy catalytic domain) - related products:
|
|
|
| |
Angiotensin Converting Enzyme 2 peptide (Carboxy catalytic domain) - other tools:
|
Contact Abcam with a Technical Enquiry about Angiotensin Converting Enzyme 2 peptide (Carboxy catalytic domain) |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Pricing information loading
